Aichi, Japan

Satoshi Nishiyama

This inventor holds 4 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1989-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoshi Nishiyama. Retrieved from https://idiyas.com/inventor/satoshi-nishiyama-t8itl2yc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Groton, CT (US) (1990)
  • Aichi, JP (1989 - 1991)
  • Chita, JP (1996)

Company Filing History:


Years Active: 1989-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Satoshi Nishiyama

Introduction: Satoshi Nishiyama is a renowned inventor based in Aichi, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Satoshi Nishiyama holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: Throughout his career, Satoshi Nishiyama has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized the way we approach complex challenges in the modern world.

Collaborations: Satoshi Nishiyama has collaborated with top companies in Japan and internationally, bringing together diverse expertise to create synergies that have led to the successful implementation of his inventions on a global scale.

Conclusion: Satoshi Nishiyama's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers, leaving a lasting impact on the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…